222 related articles for article (PubMed ID: 10963601)
1. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.
Coopman PJ; Do MT; Barth M; Bowden ET; Hayes AJ; Basyuk E; Blancato JK; Vezza PR; McLeskey SW; Mangeat PH; Mueller SC
Nature; 2000 Aug; 406(6797):742-7. PubMed ID: 10963601
[TBL] [Abstract][Full Text] [Related]
2. Syk: a new player in the field of breast cancer.
Stewart ZA; Pietenpol JA
Breast Cancer Res; 2001; 3(1):5-7. PubMed ID: 11250739
[TBL] [Abstract][Full Text] [Related]
3. Progressive loss of Syk and abnormal proliferation in breast cancer cells.
Moroni M; Soldatenkov V; Zhang L; Zhang Y; Stoica G; Gehan E; Rashidi B; Singh B; Ozdemirli M; Mueller SC
Cancer Res; 2004 Oct; 64(20):7346-54. PubMed ID: 15492255
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
[TBL] [Abstract][Full Text] [Related]
5. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
Li J; Sidell N
Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
[TBL] [Abstract][Full Text] [Related]
6. A critical role for Syk in endothelial cell proliferation and migration.
Inatome R; Yanagi S; Takano T; Yamamura H
Biochem Biophys Res Commun; 2001 Aug; 286(1):195-9. PubMed ID: 11485328
[TBL] [Abstract][Full Text] [Related]
7. Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.
Wang L; Devarajan E; He J; Reddy SP; Dai JL
Cancer Res; 2005 Nov; 65(22):10289-97. PubMed ID: 16288017
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
Yuan Y; Mendez R; Sahin A; Dai JL
Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
[TBL] [Abstract][Full Text] [Related]
9. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728
[TBL] [Abstract][Full Text] [Related]
10. [Expression of tyrosine kinase Syk in breast cancer and their clinical significance].
Ding YB; Wu ZY; Wang S; Fan P; Zha XM; Zheng W; Liu XA
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):137-9. PubMed ID: 15062056
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
Yuan Y; Liu H; Sahin A; Dai JL
Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373
[TBL] [Abstract][Full Text] [Related]
12. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.
Turner M; Mee PJ; Costello PS; Williams O; Price AA; Duddy LP; Furlong MT; Geahlen RL; Tybulewicz VL
Nature; 1995 Nov; 378(6554):298-302. PubMed ID: 7477352
[TBL] [Abstract][Full Text] [Related]
13. CD45 is essential for Fc epsilon RI signaling by ZAP70, but not Syk, in Syk-negative mast cells.
Zhang J; Siraganian RP
J Immunol; 1999 Sep; 163(5):2508-16. PubMed ID: 10452987
[TBL] [Abstract][Full Text] [Related]
14. Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report.
Inayat U; Kayani MA; Faryal R
Pol J Pathol; 2012 Jun; 63(2):106-11. PubMed ID: 22864779
[TBL] [Abstract][Full Text] [Related]
15. The ectopic expression of IFN regulatory factor 4-binding protein is correlated with the malignant behavior of human breast cancer cells.
Li P; Zhang Z; Wang Q; Li S; Zhang Y; Bian X; Chen A; Hu C
Int Immunopharmacol; 2009 Jul; 9(7-8):1002-9. PubMed ID: 19393345
[TBL] [Abstract][Full Text] [Related]
16. [Hypermethylation of syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma].
Ding YB; Wu ZY; Wang S; Zha XM; Zheng W; Liu XA; Fan P
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):290-3. PubMed ID: 15059510
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer.
Toyama T; Iwase H; Yamashita H; Hara Y; Omoto Y; Sugiura H; Zhang Z; Fujii Y
Cancer Lett; 2003 Jan; 189(1):97-102. PubMed ID: 12445683
[TBL] [Abstract][Full Text] [Related]
18. [Regulatory role of Syk gene on vascular endothelial growth factor C expression in breast cancer].
Chen XL; Li L; Zhang YJ
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):805-9. PubMed ID: 22336204
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling.
Chan AC; van Oers NS; Tran A; Turka L; Law CL; Ryan JC; Clark EA; Weiss A
J Immunol; 1994 May; 152(10):4758-66. PubMed ID: 8176201
[TBL] [Abstract][Full Text] [Related]
20. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma.
Rinaldi A; Kwee I; Taborelli M; Largo C; Uccella S; Martin V; Poretti G; Gaidano G; Calabrese G; Martinelli G; Baldini L; Pruneri G; Capella C; Zucca E; Cotter FE; Cigudosa JC; Catapano CV; Tibiletti MG; Bertoni F
Br J Haematol; 2006 Feb; 132(3):303-16. PubMed ID: 16409295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
